Register for the webinar to learn more.
Autoimmune diseases are dynamic, varied, and difficult to characterize using traditional clinical visits and static datasets. As drug developers rely on AI and biomarker-driven approaches to understand disease activity and therapeutic response, they face a fundamental limitation: most available data offers only isolated snapshots in time, missing the dynamic transitions that truly define immune-mediated conditions.
In this discussion, our speakers will explore how longitudinal, temporally relevant, multimodal data collected through direct connections with individuals can help unlock new opportunities across early R&D for immune-mediated diseases. Attendees will gain insights on how these data can be used to sharpen R&D confidence in early-phase programs and support AI-driven innovation in autoimmune drug development.
- Learn how to redesign your autoimmune data strategy by identifying gaps in current data sets and determining where continuous data collection can strengthen biomarkers and translational efforts
- Apply real world and molecular signals to detect early flare signatures and characterize transitions between disease states
- Integrate longitudinal evidence into biomarker development decisions
- Strengthen translational and early development strategy with time-based patterns in immune activity data
Offered Free by: Evidation Health
See All Resources from: Evidation Health
